Results
|
|
101.
|
NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. [electronic resource] by
- Hudes, Gary R
- Carducci, Michael A
- Choueiri, Toni K
- Esper, Peg
- Jonasch, Eric
- Kumar, Rashmi
- Margolin, Kim A
- Michaelson, M Dror
- Motzer, Robert J
- Pili, Roberto
- Roethke, Susan
- Srinivas, Sandy
Producer: 20110719
In:
Journal of the National Comprehensive Cancer Network : JNCCN vol. 9 Suppl 1
Availability: No items available.
|
|
|
102.
|
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy. [electronic resource] by
- Cho, Daniel C
- Hutson, Thomas E
- Samlowski, Wolfram
- Sportelli, Peter
- Somer, Brad
- Richards, Paul
- Sosman, Jeffrey A
- Puzanov, Igor
- Michaelson, M Dror
- Flaherty, Keith T
- Figlin, Robert A
- Vogelzang, Nicholas J
Producer: 20130205
In:
Cancer vol. 118
Availability: No items available.
|
|
|
103.
|
Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen. [electronic resource] by
- Hussain, Maha
- Corn, Paul G
- Michaelson, M Dror
- Hammers, Hans J
- Alumkal, Joshi J
- Ryan, Charles J
- Bruce, Justine Y
- Moran, Susan
- Lee, Shih-Yuan
- Lin, H Mark
- George, Daniel J
Producer: 20151013
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
|
104.
|
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma. [electronic resource] by
- Harmon, Charles S
- DePrimo, Samuel E
- Figlin, Robert A
- Hudes, Gary R
- Hutson, Thomas E
- Michaelson, M Dror
- Négrier, Sylvie
- Kim, Sindy T
- Huang, Xin
- Williams, J Andrew
- Eisen, Tim
- Motzer, Robert J
Producer: 20140227
In:
Cancer chemotherapy and pharmacology vol. 73
Availability: No items available.
|
|
|
105.
|
Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib. [electronic resource] by
- Rini, Brian I
- de La Motte Rouge, Thibault
- Harzstark, Andrea L
- Michaelson, M Dror
- Liu, Glenn
- Grünwald, Viktor
- Ingrosso, Antonella
- Tortorici, Michael A
- Bycott, Paul
- Kim, Sinil
- Bloom, Joanna
- Motzer, Robert J
Producer: 20140213
In:
Clinical genitourinary cancer vol. 11
Availability: No items available.
|
|
|
106.
|
A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524). [electronic resource] by
- Michaelson, M Dror
- Hu, Chen
- Pham, Huong T
- Dahl, Douglas M
- Lee-Wu, Chin
- Swanson, Gregory P
- Vuky, Jacqueline
- Lee, R Jeffrey
- Souhami, Luis
- Chang, Brian
- George, Asha
- Sandler, Howard
- Shipley, William
Producer: 20170710
In:
International journal of radiation oncology, biology, physics vol. 97
Availability: No items available.
|
|
|
107.
|
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study. [electronic resource] by
- Rixe, Olivier
- Bukowski, Ronald M
- Michaelson, M Dror
- Wilding, George
- Hudes, Gary R
- Bolte, Oliver
- Motzer, Robert J
- Bycott, Paul
- Liau, Katherine F
- Freddo, James
- Trask, Peter C
- Kim, Sinil
- Rini, Brian I
Producer: 20071219
In:
The Lancet. Oncology vol. 8
Availability: No items available.
|
|
|
108.
|
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial. [electronic resource] by
- Choueiri, Toni K
- Halabi, Susan
- Sanford, Ben L
- Hahn, Olwen
- Michaelson, M Dror
- Walsh, Meghara K
- Feldman, Darren R
- Olencki, Thomas
- Picus, Joel
- Small, Eric J
- Dakhil, Shaker
- George, Daniel J
- Morris, Michael J
Producer: 20170801
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
|
109.
|
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial. [electronic resource] by
- Motzer, Robert J
- Escudier, Bernard
- Tomczak, Piotr
- Hutson, Thomas E
- Michaelson, M Dror
- Negrier, Sylvie
- Oudard, Stephane
- Gore, Martin E
- Tarazi, Jamal
- Hariharan, Subramanian
- Chen, Connie
- Rosbrook, Brad
- Kim, Sinil
- Rini, Brian I
Producer: 20130628
In:
The Lancet. Oncology vol. 14
Availability: No items available.
|
|
|
110.
|
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial. [electronic resource] by
- George, Daniel J
- Hessel, Colin
- Halabi, Susan
- Michaelson, M Dror
- Hahn, Olwen
- Walsh, Meghara
- Picus, Joel
- Small, Eric J
- Dakhil, Shaker
- Feldman, Darren R
- Mangeshkar, Milan
- Scheffold, Christian
- Morris, Michael J
- Choueiri, Toni K
Producer: 20200731
In:
The oncologist vol. 24
Availability: No items available.
|
|
|
111.
|
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases. [electronic resource] by
- Lee, Richard J
- Saylor, Philip J
- Michaelson, M Dror
- Rothenberg, S Michael
- Smas, Malgorzata E
- Miyamoto, David T
- Gurski, Carol A
- Xie, Wanling
- Maheswaran, Shyamala
- Haber, Daniel A
- Goldin, Jonathan G
- Smith, Matthew R
Producer: 20140108
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
|
112.
|
Sunitinib rechallenge in metastatic renal cell carcinoma patients. [electronic resource] by
- Zama, Ivan N
- Hutson, Thomas E
- Elson, Paul
- Cleary, James M
- Choueiri, Toni K
- Heng, Daniel Y C
- Ramaiya, Nikhil
- Michaelson, M Dror
- Garcia, Jorge A
- Knox, Jennifer J
- Escudier, Bernard
- Rini, Brian I
Producer: 20110215
In:
Cancer vol. 116
Availability: No items available.
|
|
|
113.
|
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. [electronic resource] by
- Motzer, Robert J
- Hutson, Thomas E
- Tomczak, Piotr
- Michaelson, M Dror
- Bukowski, Ronald M
- Rixe, Olivier
- Oudard, Stéphane
- Negrier, Sylvie
- Szczylik, Cezary
- Kim, Sindy T
- Chen, Isan
- Bycott, Paul W
- Baum, Charles M
- Figlin, Robert A
Producer: 20070116
In:
The New England journal of medicine vol. 356
Availability: No items available.
|
|
|
114.
|
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma. [electronic resource] by
- Choueiri, Toni K
- Michaelson, M Dror
- Posadas, Edwin M
- Sonpavde, Guru P
- McDermott, David F
- Nixon, Andrew B
- Liu, Yingmiao
- Yuan, Zhenhua
- Seon, Ben K
- Walsh, Meghara
- Jivani, Manoj A
- Adams, Bonne J
- Theuer, Charles P
Producer: 20200320
In:
The oncologist vol. 24
Availability: No items available.
|
|
|
115.
|
Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. [electronic resource] by
- Sonpavde, Guru
- Pond, Gregory R
- Armstrong, Andrew J
- Clarke, Stephen J
- Vardy, Janette L
- Templeton, Arnoud J
- Wang, Shaw-Ling
- Paolini, Jolanda
- Chen, Isan
- Chow-Maneval, Edna
- Lechuga, Mariajose
- Smith, Matthew R
- Michaelson, M Dror
Producer: 20150608
In:
Clinical genitourinary cancer vol. 12
Availability: No items available.
|
|
|
116.
|
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer. [electronic resource] by
- Michaelson, M D
- Bellmunt, J
- Hudes, G R
- Goel, S
- Lee, R J
- Kantoff, P W
- Stein, C A
- Lardelli, P
- Pardos, I
- Kahatt, C
- Nieto, A
- Cullell-Young, M
- Lewis, N L
- Smith, M R
Producer: 20120907
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
117.
|
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma. [electronic resource] by
- Mahoney, Kathleen M
- Jacobus, Susanna
- Bhatt, Rupal S
- Song, Jiaxi
- Carvo, Ingrid
- Cheng, Su-Chun
- Simpson, Mekailah
- Fay, André P
- Puzanov, Igor
- Michaelson, M Dror
- Atkins, Michael B
- McDermott, David F
- Signoretti, Sabina
- Choueiri, Toni K
Producer: 20171016
In:
Clinical genitourinary cancer vol. 14
Availability: No items available.
|
|
|
118.
|
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. [electronic resource] by
- Michaelson, M Dror
- Gupta, Shilpa
- Agarwal, Neeraj
- Szmulewitz, Russell
- Powles, Thomas
- Pili, Roberto
- Bruce, Justine Yang
- Vaishampayan, Ulka
- Larkin, James
- Rosbrook, Brad
- Wang, Erjian
- Murphy, Danielle
- Wang, Panpan
- Lechuga, Maria Josè
- Valota, Olga
- Shepard, Dale R
Producer: 20200727
In:
The oncologist vol. 24
Availability: No items available.
|
|
|
119.
|
Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125]. [electronic resource] by
- Choueiri, Toni K
- Hessel, Colin
- Halabi, Susan
- Sanford, Ben
- Michaelson, M Dror
- Hahn, Olwen
- Walsh, Meghara
- Olencki, Thomas
- Picus, Joel
- Small, Eric J
- Dakhil, Shaker
- Feldman, Darren R
- Mangeshkar, Milan
- Scheffold, Christian
- George, Daniel
- Morris, Michael J
Publication details: European journal of cancer (Oxford, England : 1990) 11 2018
In:
European journal of cancer (Oxford, England : 1990) vol. 103
Availability: No items available.
|
|
|
120.
|
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update. [electronic resource] by
- Choueiri, Toni K
- Hessel, Colin
- Halabi, Susan
- Sanford, Ben
- Michaelson, M Dror
- Hahn, Olwen
- Walsh, Meghara
- Olencki, Thomas
- Picus, Joel
- Small, Eric J
- Dakhil, Shaker
- Feldman, Darren R
- Mangeshkar, Milan
- Scheffold, Christian
- George, Daniel
- Morris, Michael J
Producer: 20190111
In:
European journal of cancer (Oxford, England : 1990) vol. 94
Availability: No items available.
|